Axio Data Monitoring Committee
Data monitoring and safety oversight platform for clinical trials
Platform · Cloud SaaSCompany source
Company profile
About Cytel
Cytel is a global clinical research organization that delivers advanced analytics, data science, and software solutions to pharmaceutical and biotechnology companies throughout the drug development lifecycle. The company specializes in innovative trial design methodologies including adaptive trial designs, Bayesian approaches, and model-informed drug development. Cytel's comprehensive service portfolio spans discovery and preclinical research, Phase I-III clinical trials, commercialization strategies, and real-world evidence generation. The organization offers strategic consulting, functional service provider models, and project-based analytical solutions tailored to client needs. Cytel's proprietary software platforms include East Horizon for trial design, the Xact software suite (including StatXact), Enforesys for trial implementation, and LiveSLR for systematic literature reviews. The company serves diverse therapeutic areas with particular expertise in rare diseases, oncology, and central nervous system disorders. Cytel provides specialized capabilities in health economics and outcomes research (HEOR), market access strategy, regulatory compliance, data monitoring committees, and real-world data analytics. Their solutions integrate advanced statistical methods with regulatory expertise to optimize trial efficiency, enhance probability of success, and accelerate time to market for new therapeutics.
Company description Cytel official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Cytel?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Central Nervous System disorders
- Oncology
- Pediatrics
- Rare Diseases
Who it serves
- Biotech
- Pharma
Deployment & integration
Cloud Saas · On Premise deployment with recorded integration context.
Geographic context
MarketsGlobal
Company sourceOfficial website
Company milestones
Platform expansion
Company milestone context is currently being developed.
Partnerships
Recorded partners
- stève consultants
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
East Horizon
Platform for clinical trial design and simulation
Platform · Cloud SaaSCompany source
Enforesys
Trial implementation and decision support software
Software · Cloud SaaSCompany source
LiveSLR
Software for systematic literature reviews in clinical research
Software · Cloud SaaSCompany source
Xact Software Suite (StatXact)
Statistical software for clinical trial analysis
Software · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Estimating clinical and economic impacts and cost-effectiveness of introducing 20-valent pneumococcal conjugate vaccine in Taiwan's pediatric National Immunization Program and impacts of a delayed implementation.Human vaccines & immunotherapeutics · Dec 1, 2026
Consistent adherence to biologic therapies is critical for improving outcomes in asthma.The journal of allergy and clinical immunology. Global · Nov 1, 2026
Perspectives on the Use of a Bayesian Approach in Designing Seamless Phase 2/3 Clinical Trials with Dose Selection, Early Stopping for Futility and Efficacy, or Sample Size Re-estimation.Therapeutic innovation & regulatory science · Oct 7, 2026
MAIA frailty subgroup analysis: long-term follow-up with daratumumab plus lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma.Leukemia · Oct 6, 2026
Maternal health, neonatology and perinatology towards a standardized outcome set for clinical trials in Hemolytic Disease of the Fetus and Newborn (HDFN): preliminary findings from two European advisory boards.Maternal health, neonatology and perinatology · Sep 25, 2026
Real-World Systemic Treatment Outcomes for Moderate-to-Severe Atopic Dermatitis in Children by Skin Color: 4-Year Results from the observational, international, real-world PEDISTAD Registry.Journal of the American Academy of Dermatology · Sep 21, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Cytel
Recent articles published on Cytel's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.